Loading...
Monitoring therapeutic monoclonal antibodies in brain tumor
Bevacizumab induces normalization of abnormal blood vessels, making them less leaky. By binding to vascular endothelial growth factor, it indirectly attacks the vascular tumor mass. The optimal delivery of targeted therapies including monoclonal antibodies or anti-angiogenesis drugs to the target ti...
Saved in:
| Published in: | MAbs |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622724/ https://ncbi.nlm.nih.gov/pubmed/25484065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.34405 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|